Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06703970 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain
A NA study, sponsored by LifeBridge Health.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT06703970 is a NA study that has completed, run by LifeBridge Health. The registered enrollment target is 52 participants.
The verdict
NCT06703970, a NA study, has completed, sponsored by LifeBridge Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Prospective, multi-center, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of knee osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.
Interventions
- DRUG Corticosteroid Injection
- DEVICE Platelet Rich Plasma Joint Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2024-07-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06703970
The ClinicalTrials.gov registry entry for NCT06703970 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Corticosteroid Injection is the first listed.
NCT06703970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06703970 about?
NCT06703970 is a clinical study titled "Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain". Prospective, multi-center, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of knee osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and ...
What is the current status of trial NCT06703970?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2022-02-02. Estimated completion is 2024-07-16.
What interventions are being tested in trial NCT06703970?
The interventions under investigation include: Corticosteroid Injection (DRUG), Platelet Rich Plasma Joint Injection (DEVICE).
Who is sponsoring clinical trial NCT06703970?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.